ArticleBMC cancer2023

Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy.

Yiqun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.